Final year

Respiratory Therapeutics

Respiratory drug therapy and assessment in UK practice, for final-year medical students preparing for finals and the Prescribing Safety Assessment, final-year pharmacy students and foundation doctors. It covers stepwise asthma management, inhaler technique, acute severe asthma in adults and children, COPD inhaled therapy and infective exacerbations, controlled oxygen and type 2 respiratory failure, and respiratory examination, chest radiographs and bronchiolitis.

3 modules · 21 lessons 4 h EN

What you will be able to do

  • Take a structured respiratory history and perform a systematic respiratory examination, then present the findings concisely and link them to a working diagnosis.
  • Select an inhaler device for a patient with asthma or COPD, justify the choice, and demonstrate correct technique, including spacer use in adults and children.
  • Construct stepwise treatment plans for chronic asthma and COPD using current British National Formulary doses, explaining where practice varies by region or formulary.
  • Assess and begin immediate treatment of acute severe asthma in an adult or child, covering oxygen, inhaled and systemic bronchodilators and corticosteroid therapy, and identify when to escalate.
  • Prescribe controlled oxygen with target saturations for a patient at risk of type 2 respiratory failure and interpret serial arterial blood gases to detect rising carbon dioxide.
  • Write complete, safe prescriptions for an infective exacerbation of COPD and check them against prescribing safety rules before signing.
  • Interpret a chest radiograph for pneumothorax and describe the clinical and radiographic features of a pleural effusion.
  • Recognise the severity of bronchiolitis in an infant and outline supportive management and referral criteria.

About this course

Respiratory Therapeutics is a practical course on drug therapy and assessment for common respiratory conditions. It is written for final-year medical and pharmacy students and foundation doctors preparing for finals and the Prescribing Safety Assessment. Teaching is set in UK practice, with British National Formulary dosing and NICE-style guidance. Guidance and formularies differ between regions and institutions; where practice varies, the course says so rather than presenting one approach as universal.

Module 1: Asthma

The first module covers the stepwise management of chronic asthma, the distinction between preventer and reliever therapy, and the devices used to deliver inhaled drugs. You will work through inhaler technique for pressurised metered-dose inhalers, dry powder inhalers and spacers, including common errors and how to correct them.

  • Stepwise management of chronic asthma, including when to step up and step down.
  • Preventer versus reliever therapy: inhaled corticosteroids, long-acting beta2-agonists and leukotriene receptor antagonists.
  • Inhaler devices and technique, with practical assessment of technique.
  • Acute severe asthma in adults and children: severity assessment, oxygen, nebulised salbutamol and ipratropium, systemic corticosteroids such as prednisolone, and escalation.

Module 2: COPD and respiratory failure

The second module moves to chronic obstructive pulmonary disease. It covers long-acting bronchodilators and inhaled corticosteroids, and the autonomic pharmacology that explains how these drugs work. You will review treatment, consider when to escalate or de-escalate, and manage infective exacerbations.

  • Long-acting beta2-agonists and long-acting muscarinic antagonists in COPD.
  • Inhaled corticosteroids: benefits, risks and place in therapy.
  • Autonomic pharmacology: beta2 receptors, muscarinic receptors and the drugs that act on them.
  • Infective exacerbations of COPD: antibiotics, corticosteroids, non-invasive ventilation and referral criteria.
  • Controlled oxygen therapy, target saturations and recognising type 2 respiratory failure.

Module 3: Respiratory assessment and acute presentations

The third module builds core assessment skills. It covers the systematic respiratory examination and the signs of pleural effusion, reading the chest radiograph for pneumothorax and effusion, and bronchiolitis in infants. Acute presentations are used to practise putting assessment findings together with drug therapy decisions.

How the course is taught

Every module pairs teaching with hands-on practice. You will work through branching clinical cases, prescribing scenarios checked against safety rules, and timed objective structured clinical examination (OSCE) stations. The asthma and COPD modules each end with a quiz. A final exam gates the certificate.

Doses used in teaching are examples for learning, not prescribing advice. The platform's deterministic rules, not the course text, decide whether a prescription is safe.

Who it suits

The course suits final-year medical and pharmacy students and foundation doctors who need to prescribe and review respiratory drugs safely. It also supports nurses and physician associates who want a structured refresher, provided they work within their local scope of practice.

Content provided through Oskela is intended for education and training. It is not a substitute for professional clinical judgment, institutional protocols, current formularies, prescribing information, or specialist consultation.

Curriculum

3 modules · 21 lessons

Before you start

  • Completed a foundation course in respiratory anatomy and physiology, including gas exchange and lung mechanics.
  • Basic autonomic pharmacology, including beta-2 adrenergic receptors, muscarinic receptors and the action of corticosteroids.
  • Confidence in taking a focused history and performing a basic physical examination in a clinical skills setting.

Who this is for

  • Final-year medical students preparing for finals and the Prescribing Safety Assessment.
  • Final-year pharmacy students preparing for prescribing or clinical pharmacy assessments.
  • Foundation doctors in their first two years of practice who review respiratory patients.
  • Nursing students on respiratory or acute medical placements.

Your instructor

PL

Platform Administrator

Other courses

  • Pharmacokinetics

    A free course for medical, pharmacy and nursing students who want a working grasp of how the body handles drugs. It covers absorption, distribution, metabolism and excretion, then clearance, volume of distribution, half-life and bioavailability, and applies them to concentration-time curves, steady state, loading and maintenance doses, and dose adjustment when renal or hepatic function changes.

  • Therapeutic Drug Monitoring and Prescribing Calculations

    For final-year medical students preparing for finals and the Prescribing Safety Assessment (PSA), final-year pharmacy students, and foundation doctors. Topics: prescribing calculations, applied pharmacokinetics and therapeutic drug monitoring of narrow-therapeutic-index drugs, and interpreting potassium, sodium, renal, thyroid and liver results. UK practice, BNF dosing and NICE-style guidance. Pharmacy students do not sit the PSA.

  • Adverse Drug Reactions and Pharmacovigilance

    For final-year medical students preparing for finals and the PSA, final-year pharmacy students and foundation doctors. Covers what counts as an ADR, A to F and DoTS classification, WHO-UMC and Naranjo causality, severity versus seriousness, type A reactions, allergy, organ-specific harm, and Yellow Card reporting. Every module closes with a quiz. Practice includes prescribing scenarios, timed OSCE stations and ADR cases to assess and report.

  • Safe Prescribing in Special Populations

    Prescribing where standard adult doses cause harm, in UK practice with British National Formulary dosing, for final-year medical students preparing for finals and the Prescribing Safety Assessment, final-year pharmacy students and foundation doctors. It covers renal and hepatic impairment, pregnancy and breastfeeding, weight-based dosing in children, polypharmacy and deprescribing in older people, and serious interactions and adverse drug reactions.

  • Pain, Neurology and Mental Health Prescribing

    Pain, neurological and psychiatric prescribing in UK practice, for final-year medical students preparing for finals and the Prescribing Safety Assessment, final-year pharmacy students and foundation doctors. It covers the analgesic ladder, opioid and NSAID safety, neuropathic pain, epilepsy and valproate risk, migraine, Parkinson's disease, depression, lithium, anxiety and sleep, psychosis, rapid tranquillisation and delirium. Doses follow the British National Formulary.

  • Acute Medicine, Poisoning and Emergencies

    Acute medicine and emergency prescribing in UK practice, for final-year medical students preparing for finals and the Prescribing Safety Assessment, final-year pharmacy students and foundation doctors. It covers ABCDE assessment, basic life support, anaphylaxis, poisoning and antidotes for paracetamol, opioids and lithium, alcohol withdrawal, intravenous fluids, acute kidney injury and hyperkalaemia, blood gases, upper GI and variceal bleeding, status epilepticus and subarachnoid haemorrhage.

  • Diabetes and Endocrine Therapeutics

    Diabetes and endocrine prescribing in UK practice, for final-year medical students preparing for finals and the Prescribing Safety Assessment, final-year pharmacy students and foundation doctors. It covers choosing and intensifying type 2 diabetes therapy, insulin regimens and sick-day rules, hypoglycaemia, the variable rate insulin infusion, DKA and HHS, thyroid disease, corticosteroids and adrenal crisis, and calcium and sodium disorders. Dosing follows the British National Formulary.

  • Antimicrobial Prescribing and Infection Management

    Antibiotic prescribing and infection management in UK practice, for final-year medical students preparing for finals and the Prescribing Safety Assessment, final-year pharmacy students and foundation doctors. It covers the antibiotic classes, stewardship and C. difficile, penicillin allergy, gentamicin dosing, sepsis, pneumonia, COPD exacerbations and tuberculosis, urinary, skin and soft tissue infection, meningitis, malaria and dengue in returning travellers, and febrile neutropenia.